Intuitive Surgical (ISRG) Cash from Investing Activities (2009 - 2026)
Intuitive Surgical (ISRG) posted quarterly Cash from Investing Activities of -$26.6 million for Q2 2026, down 110.2% year-over-year from $260.7 million in Q2 2025, and up 97.09% quarter-over-quarter from -$914.5 million in Q1 2026.
Intuitive Surgical (ISRG) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Intuitive Surgical's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$26.6 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities fell 110.2% year-over-year to -$26.6 million; the TTM figure through Jun 2026 stood at -$749.5 million (up 65.98% YoY), while the FY2025 annual figure was $665.8 million, up 120.34% from the prior year.
- Cash from Investing Activities for Q2 2026 stood at -$26.6 million, up from -$914.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $574.8 million in Q4 2022, with the low at -$1.4 billion in Q3 2024.
- The 5-year median for Cash from Investing Activities is -$77.6 million (2024), against an average of -$141.0 million.
- The sharpest annual moves came in 2023 and 2026: Cash from Investing Activities jumped 366.93% in 2023, then sank 528.34% in 2026.
- Intuitive Surgical's Cash from Investing Activities stood at $574.8 million in 2022, then tumbled by 281.66% to -$1.0 billion in 2023, then dropped by 21.07% to -$1.3 billion in 2024, then surged by 83.44% to -$209.4 million in 2025, then soared by 87.3% to -$26.6 million in 2026.
- Business Quant data shows ISRG's Cash from Investing Activities at -$26.6 million in Q2 2026, -$914.5 million in Q1 2026, and -$209.4 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -82.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.60 Mn |
| Jun 30, 2026 | -26.60 Mn |
| Mar 31, 2026 | -914.50 Mn |
| Mar 31, 2026 | -914.50 Mn |
| Dec 31, 2025 | -209.40 Mn |
| Dec 31, 2025 | -209.40 Mn |
| Sep 30, 2025 | 401.00 Mn |
| Sep 30, 2025 | 401.00 Mn |
| Jun 30, 2025 | 260.70 Mn |
| Jun 30, 2025 | 260.70 Mn |
| Mar 31, 2025 | 213.50 Mn |
| Mar 31, 2025 | 213.50 Mn |
| Dec 31, 2024 | -1.26 Bn |
| Dec 31, 2024 | -1.26 Bn |
| Sep 30, 2024 | -1.41 Bn |
| Sep 30, 2024 | -1.41 Bn |
| Jun 30, 2024 | -467.10 Mn |
| Jun 30, 2024 | -467.10 Mn |
| Mar 31, 2024 | -128.50 Mn |
| Mar 31, 2024 | -128.50 Mn |